Table 6.
The first 25 query results for query #12
| drug name | disease2 _name |
|---|---|
| (s)-rolipram | Schizophrenia |
| (s)-rolipram | Autistic Disorder |
| (s)-rolipram | Bipolar Disorder |
| (s)-rolipram | Depression |
| ACE INHIBITORS, PLAIN | Angioneurotic Edema |
| ACE INHIBITORS, PLAIN | Hypertension |
| ACE INHIBITORS, PLAIN | Hypertrophy, Left Ventricular |
| ACE INHIBITORS, PLAIN | Coronary Disease |
| ACE INHIBITORS, PLAIN | Alzheimer Disease |
| ACE INHIBITORS, PLAIN | nondiabetic proteinuric nephropathy |
| ACE INHIBITORS, PLAIN | Alcoholism |
| ACE INHIBITORS, PLAIN | Abnormalities |
| ACE INHIBITORS, PLAIN | Fetal Death |
| ACE INHIBITORS, PLAIN | Cardiovascular Abnormalities |
| ACE INHIBITORS, PLAIN | Cardiovascular Diseases |
| ACE INHIBITORS, PLAIN | Cough |
| ACE INHIBITORS, PLAIN | Heart Failure |
| ACE INHIBITORS, PLAIN | Kidney Diseases |
| ANGIOTENSIN II ANTAGONISTS AND CALCIUM CHANNEL BLOCKERS | Cardiovascular Diseases |
| ANGIOTENSIN II ANTAGONISTS AND CALCIUM CHANNEL BLOCKERS | Hypertension |
| ANTIPSYCHOTICS | Schizophrenia |
| BETA BLOCKING AGENTS | Abnormalities |
| BETA BLOCKING AGENTS | Fetal Death |
| BETA BLOCKING AGENTS | Cardiovascular Abnormalities |
| atenolol | glomerulosclerosis |
| ... | ... |
A selection of existing marketed drugs in TMKB that might potentially be candidates for AD because they are known to modulate genes that are implicated in the disease.